Latest News in the pharma Industry

Market News

Acordia's NDA generates Refusal to File letter from FDA

Acordia's NDA generates Refusal to File letter from FDA

29 Aug 2017

FDA cites two manufacturing concerns.

Read more 
Berg and AstraZeneca collaborate to identify new therapeutic targets to treat neurological disorders

Berg and AstraZeneca collaborate to identify new therapeutic targets to treat neurological disorders

28 Aug 2017

Collaboration to focus on a disease target in Parkinson's disease with Berg's Interrogative Biology technology.

Read more 
Sanofi completes the acquisition of Protein Sciences

Sanofi completes the acquisition of Protein Sciences

28 Aug 2017

An innovative quadrivalent influenza vaccine will complement Sanofi Pasteur vaccine portfolio.

Read more 
Biogen’s adalimumab biosimilar referencing Humira, is approved in the EU

Biogen’s adalimumab biosimilar referencing Humira, is approved in the EU

28 Aug 2017

Biogen becomes the first company with approved biosimilars for the three most prescribed anti-TNF biologic treatments in Europe.

Read more 
Class action lawsuit filed on behalf of investors in Teva

Class action lawsuit filed on behalf of investors in Teva

28 Aug 2017

Complaint alleges Teva failed to disclose the poor performance of its US generics business and the subsequent goodwill impairment charge stemming from the company’s purchase of Actavis Generics.

Read more 
Boehringer Ingelheim receives FDA approval for its Humira biosimilar

Boehringer Ingelheim receives FDA approval for its Humira biosimilar

29 Aug 2017

Cyltezo approved for the treatment of multiple chronic inflammatory diseases.

Read more 
MedPharm strengthens management on back of US success

MedPharm strengthens management on back of US success

24 Aug 2017

Appointments come as global leader in contract topical and transdermal pharmaceutical development benefits from increased revenues.

Read more 
Otsuka and Mylan sign license agreement to commercialize delamanid for MDR-TB in high-burden countries

Otsuka and Mylan sign license agreement to commercialize delamanid for MDR-TB in high-burden countries

24 Aug 2017

Mylan granted an exclusive license by Otsuka to prioritize access to Deltyba in South Africa and India.

Read more 
Charles River Laboratories acquires Brains On-Line

Charles River Laboratories acquires Brains On-Line

23 Aug 2017

Establishes Charles River as a premier source for CNS contract research services.

Read more 
Bavarian Nordic closes transaction with Janssen Pharmaceuticals

Bavarian Nordic closes transaction with Janssen Pharmaceuticals

22 Aug 2017

Collaboration grants Janssen the exclusive rights to Bavarian Nordic’s MVA-BN technology for two additional programs, targeting vaccines against hepatitis B virus and the human immunodeficiency virus.

Read more 
Amgen and Humana partner for improved health outcomes and efficiency

Amgen and Humana partner for improved health outcomes and efficiency

22 Aug 2017

Partnership to target multiple serious diseases using real world data studies.

Read more 
Spray drying specialist to invest €19 million in GMP facility expansion

Spray drying specialist to invest €19 million in GMP facility expansion

22 Aug 2017

Investment is in response to increased market for spray drying and capsule filling for dry powder inhalers.

Read more